Daily non-political popular news in brief.
Immune system can drive cancers into dormant state
11-18-2007 · EurekAlert!A multinational team of researchers has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it. Scientists have been working for years to use the immune system to eradicate cancers. The new findings prove an alternate to this approach exists: When the cancer can't be killed with immune attacks, it may be possible to find ways to use the immune system to contain it.
Read more »
Keywords: immune, system, drive, cancers, dormant, state, cancer
« Previous | Next »
Similar news on "Immune system can drive cancers into dormant state":
- Bursts of waves drive immune system 'soldiers' toward invaders
08-13-2007 · EurekAlert!
Scientists have discovered that torrents of microscopic waves propel white blood cells toward invading microbes. The discovery -- recorded on videotape -- holds the potential for better understanding and treatment of cancer and heart disease.
Similar news · Read more »
- Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
04-17-2007 · EurekAlert!
As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
Similar news · Read more »
- Researchers discover method for identifying how cancer evades the immune system
07-02-2007 · EurekAlert!
One of the fundamental traits of a tumor -- how it avoids the immune system -- might become its greatest vulnerability, according to researchers from the University of Southern California. Their findings, demonstrated in human breast and colorectal cancers, indicate that a technique for determining a tumor's "immune signature," could be useful for diagnosing and treating specific cancers.
Similar news · Read more »
- Stanford researchers identify immune dysfunction in melanoma patients
05-07-2007 · EurekAlert!
Researchers at Stanford have begun to shed light on why the human immune system isn't able to stop such cancers as melanoma, suggesting answers that could pave the way for better treatment of this often-fatal illness. In a small study, the scientists found that the immune cells in a majority of people with this deadly skin cancer fail to respond properly to a molecule called interferon, which normally activates the immune system.
Similar news · Read more »
- Immune system 'escape hatch' gives cancer cells traction
07-16-2007 · EurekAlert!
Scientists at Johns Hopkins and elsewhere say they have mapped out an escape route that cancers use to evade the body's immune system, allowing the disease to spread unchecked.
Similar news · Read more »
- UBC researchers discover 'instruction manual' that tells cancers how to hide from immune system
11-08-2007 · EurekAlert!
A mechanism that creates an "invisibility cloak" for certain cancer cells and allows them to hide from the immune system has been uncovered by a team of researchers at the University of British Columbia.
Similar news · Read more »
- A chemotherapy drug packs a one-two punch
02-20-2007 · EurekAlert!
How cancer cells are killed could turn out to be an important element in activating a patient's immune system. A new study shows that one chemotherapy drug may kill tumor cells in such a way that the immune system can recognize the cancerous cells and help fight the disease more effectively.
Similar news · Read more »
- Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
04-18-2007 · EurekAlert!
Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
Similar news · Read more »
- Vaccine improves event-free survival for leukemia patients
12-09-2007 · EurekAlert!
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than nonresponders, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Similar news · Read more »
- Novel vaccine concept developed by scientists at the Wistar Institute
01-31-2008 · EurekAlert!
A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
Similar news · Read more »
